Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Expensify to Announce Q3 2022 Results


Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced that the company's third quarter financial results will be released after market close on Thursday, November 10th, 2022.

Expensify will host a live video call to discuss its Q3 2022 results on Thursday, November 10th, 2022 at 2pm PT / 5pm ET. The link to the call will be available that day on the company's Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars.

After the call, the following will be made available at investors.expensify.com:

To get started using Expensify or to learn more, head over to use.expensify.com.

About Expensify

Expensify is a payments superapp that helps individuals and businesses around the world simplify the way they manage money. More than 12 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, payroll, and travel booking in one app. All free. Whether you own a small business, manage a team, or close the books for your clients, Expensify makes it easy so you have more time to focus on what really matters.


These press releases may also interest you

at 12:05
Be Biopharma Announces New Preclinical Data for Novel B Cell Medicine for the Potential Treatment of Hypophosphatasia
Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today presented results from new preclinical research demonstrating production of active ALP by a BCM, which highlights BCMs as a...

at 12:05
Kondukto announces Bring-Your-Own-Data (BYOD)
Today Kondukto Inc., the leading Application Security Orchestration & Posture Management platform for cloud and on-premise workloads, announces "Bring-Your-Own-Data" (BYOD) which allows enterprises to integrate their unique data-streams into the...

at 11:50
EGLE Therapeutics Strengthens its Leadership Team with the Appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer and its Board of Directors with Appointment of John Celebi, MBA, as Independent Board Member
EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Pejvack Motlagh MD, MSc, as Chief...

at 11:35
Productivity in the AI Era: ChatGPT's Role in Transforming Business Operations Outlined in New Blueprint From Info-Tech Research Group
Generative AI tools like ChatGPT promise to reshape traditional workflows by streamlining tasks, automating research, and freeing up...

at 11:32
IDTechEx Explores Printed Electronics in Electrified and Autonomous Mobility
Electrification, autonomy, and vehicle ownership saturation are causing a technological revolution in the automotive sector. These automotive meta-trends are driving drastic changes in electronic component requirements and present a high-volume...

at 11:30
WomenHeart and Bayer Join Forces to Enhance Heart Health Awareness and Education Among Women Across the U.S.
WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Cardiovascular Disease initiative. This groundbreaking partnership aims to bolster...

More news about Science and technology...


News published on and distributed by: